Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Triple Quadrupole Mass Spectrometer

By Drug Discovery Trends Editor | June 15, 2012

Shimadzu Scientific Instruments’ LCMS-8040 is a triple quadrupole mass spectrometer, which combines improved ion optics and collision cell technology with ultra-fast technologies to expand the application range and ensure high-sensitivity, high-throughput analysis at lower levels of detection.

The LCMS-8040 features the world’s fastest polarity switching at 15 ms and a high-speed scanning rate of 15,000 µ/sec. The instrument achieves MRM transition speeds up to 555 MRMs per second with UFsweeper II collision cell technology. UFsweeper II features high-speed ion transport technology that maintains sensitivity and suppresses crosstalk, even for high-speed or simultaneous multi-components analyses. 

The LCMS-8040 incorporates the UF-Lens ion optics, which integrate two multi-pole RF ion guides, and UFsweeper II technology to provide higher multiple reaction monitoring (MRM) sensitivity. A five-fold increase in sensitivity (reserpine, S/N ratio) has been achieved by improving ion focusing and minimizing ion losses between multi-pole lenses. These improvements also yield higher sensitivity for scan mode measurements. The combination of speed and sensitivity expands the potential range of LC/MS/MS applications and makes the 8040 suitable for qualitative/quantitative analysis.

LabSolutions LCMS software offers a variety of data processing features, including a Quantitation Browser, which processes multiple analytes; and a data browser, which allows users to analyze and compare multiple sets of data in the same window. Users also can optimize MRM parameters with LabSolutions software by utilizing automated flow injection analysis.

Shimadzu provides a variety of method packages to eliminate the need for MRM determination and chromatographic method development. Additionally, the LCMS-8040 features a user-friendly interface and compatibility with LCMS-8030 MRM parameters for easy method transfer.

Shimadzu Scientific Instruments


Filed Under: Drug Discovery

 

Related Articles Read More >

Lokavant’s Spectrum v15 uses AI to cut trial-feasibility modeling from weeks to minutes
Prime time for peptide-based drug discovery 
Why smaller, simpler molecular glues are gaining attention in drug discovery
Glass vial, pipette and woman scientist in laboratory for medical study, research or experiment. Test tube, dropper and professional female person with chemical liquid for pharmaceutical innovation
Unlocking ‘bench-to-bedside’ discoveries requires better data sharing and collaboration
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE